Boston Pharmaceuticals Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
72
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
- Investments
-
2
Boston Pharmaceuticals General Information
Description
Operator of a drug development company intended to acquire clinical assets at various stages of their development. The company partners with academic, biotech and biopharma groups to develop new medicines by acquiring and transforming innovative molecules across multiple therapeutic areas, providing differentiated solutions that improve patients' lives.
Contact Information
Website
www.bostonpharmaceuticals.comCorporate Office
- 55 Cambridge Parkway
- Suite 400
- Cambridge, MA 02142
- United States
Corporate Office
- 55 Cambridge Parkway
- Suite 400
- Cambridge, MA 02142
- United States
Boston Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Boston Pharmaceuticals Comparisons
Industry
Financing
Details
Boston Pharmaceuticals Competitors (52)
One of Boston Pharmaceuticals’s 52 competitors is Mission Therapeutics, a Venture Capital-Backed company based in Cambridge, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Mission Therapeutics | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| Cycle pharma | Corporation | Cambridge, United Kingdom | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| Lead Pharma | Venture Capital-Backed | Oss, Netherlands | ||||
| Pfizer Manufacturing Austria | Corporation | Orth An Der Donau, Austria |
Boston Pharmaceuticals Patents
Boston Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2015244025-A1 | Binding molecules specific for il-21 and uses thereof | Active | 08-Apr-2014 | ||
| US-10022443-B2 | Antibodies specific for il-21 and uses thereof | Active | 08-Apr-2014 | ||
| US-20170173149-A1 | Binding molecules specific for il-21 and uses thereof | Active | 08-Apr-2014 | ||
| ES-2814150-T3 | Il-21-specific binding molecules and uses thereof | Active | 08-Apr-2014 | ||
| US-11529415-B2 | Antibodies specific for il-21 and uses thereof | Active | 08-Apr-2014 | A61P37/00 |
Boston Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Boston Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Boston Pharmaceuticals Acquisitions (2)
Boston Pharmaceuticals’s most recent deal was a Merger/Acquisition with Novartis (Candidate MAK181). The deal was made on 03-Oct-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Novartis (Candidate MAK181) | 03-Oct-2018 | Merger/Acquisition | Buildings and Property | ||
| Novartis (Worldwide Rights to LYS228, IID572 and MAK181) | 03-Oct-2018 | Merger/Acquisition | Buildings and Property |
Boston Pharmaceuticals FAQs
-
When was Boston Pharmaceuticals founded?
Boston Pharmaceuticals was founded in 2015.
-
Where is Boston Pharmaceuticals headquartered?
Boston Pharmaceuticals is headquartered in Cambridge, MA.
-
What is the size of Boston Pharmaceuticals?
Boston Pharmaceuticals has 72 total employees.
-
What industry is Boston Pharmaceuticals in?
Boston Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Boston Pharmaceuticals a private or public company?
Boston Pharmaceuticals is a Private company.
-
What is Boston Pharmaceuticals’s current revenue?
The current revenue for Boston Pharmaceuticals is .
-
How much funding has Boston Pharmaceuticals raised over time?
Boston Pharmaceuticals has raised $600M.
-
Who are Boston Pharmaceuticals’s investors?
Gurnet Point Capital has invested in Boston Pharmaceuticals.
-
Who are Boston Pharmaceuticals’s competitors?
Mission Therapeutics, Cycle pharma, Novartis, Lead Pharma, and Pfizer Manufacturing Austria are some of the 52 competitors of Boston Pharmaceuticals.
-
When was Boston Pharmaceuticals acquired?
Boston Pharmaceuticals was acquired on 01-Aug-2023.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
